NasdaqGS:ALGNMedical Equipment
Align Technology (ALGN): Assessing Valuation After Q2 Revenue Miss and Legal Scrutiny Spurs Investor Uncertainty
Align Technology (ALGN) is back in the spotlight after a series of tough headlines for investors to consider. The company recently reported a revenue miss for the second quarter of 2025 and sharply reduced its growth outlook for the rest of the year, directly linking the guidance cut to economic uncertainty and softer demand. Almost immediately, multiple law firms launched investigations into possible securities law violations, which has unsettled some shareholders and captured Wall Street’s...